|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 8/09/12 Prestige Consumer Healthcare Inc. 10-Q 6/30/12 97:20M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 892K
2: EX-10.1 Director Compensation Policy HTML 29K
3: EX-10.2 Agreement of Lease Btw Ra 660 White Plains Rd and HTML 360K
Pb
4: EX-31.1 Certification of Principal Executive Officer HTML 34K
5: EX-31.2 Certification of Principal Financial Officer HTML 34K
6: EX-32.1 Certification of Principal Executive Officer HTML 27K
7: EX-32.2 Certification of Principal Financial Officer HTML 28K
66: R1 Document and Entity Information HTML 45K
53: R2 Consolidated Statements of Income and HTML 119K
Comprehensive Income
64: R3 Consolidated Balance Sheets HTML 140K
69: R4 Consolidated Balance Sheets (Parentheticals) HTML 49K
89: R5 Consolidated Statements of Cash Flows HTML 135K
55: R6 Business and Basis of Presentation HTML 64K
63: R7 Acquisitions HTML 73K
48: R8 Accounts Receivable HTML 41K
38: R9 Inventories HTML 38K
90: R10 Property and Equipment HTML 44K
71: R11 Goodwill HTML 57K
70: R12 Intangible Assets HTML 74K
76: R13 Other Accrued Liabilities HTML 41K
77: R14 Long-Term Debt HTML 87K
74: R15 Fair Value Measurements HTML 46K
78: R16 Stockholders' Equity HTML 42K
65: R17 Accumulated Other Comprehensive Income (Loss) HTML 44K
67: R18 Earnings Per Share HTML 53K
73: R19 Share-Based Compensation HTML 124K
97: R20 Income Taxes HTML 35K
84: R21 Commitments and Contingencies HTML 61K
59: R22 Concentrations of Risk HTML 38K
72: R23 Business Segments HTML 129K
61: R24 Gain on Settlement HTML 31K
29: R25 Condensed Consolidating Financial Statements HTML 1.00M
86: R26 Subsequent Events HTML 30K
93: R27 Business and Basis of Presentation (Policies) HTML 131K
43: R28 Business and Basis of Presentation (Tables) HTML 31K
42: R29 Acquisitions (Tables) HTML 56K
46: R30 Accounts Receivable (Tables) HTML 38K
47: R31 Inventories (Tables) HTML 35K
49: R32 Property and Equipment (Tables) HTML 40K
21: R33 Goodwill (Tables) HTML 56K
82: R34 Intangible Assets (Tables) HTML 72K
57: R35 Other Accrued Liabilities (Tables) HTML 41K
60: R36 Long-Term Debt (Tables) HTML 60K
33: R37 Accumulated Other Comprehensive Income (Loss) HTML 48K
(Tables)
96: R38 Earnings Per Share (Tables) HTML 49K
14: R39 Share-Based Compensation (Tables) HTML 110K
50: R40 Commitments and Contingencies (Tables) HTML 59K
88: R41 Business Segments (Tables) HTML 129K
31: R42 Condensed Consolidating Financial Statements HTML 1.00M
(Tables)
41: R43 Business and Basis of Presentation (Other Balance HTML 31K
Sheet and Income Statement Items) (Details)
45: R44 Business and Basis of Presentation (Property and HTML 30K
Equipment) (Details)
54: R45 Business and Basis of Presentation (Intangible HTML 28K
Assets) (Details)
20: R46 Acquisitions (Narrative) (Details) HTML 77K
37: R47 Acquisitions (Purchase Price Allocation) (Details) HTML 40K
16: R48 Acquisitions (Pro Forma Information) (Details) HTML 42K
87: R49 Accounts Receivable (Details) HTML 35K
30: R50 Inventories (Details) HTML 41K
83: R51 Property and Equipment (Details) HTML 46K
34: R52 Goodwill (Details) HTML 50K
51: R53 Intangible Assets (Details) HTML 73K
15: R54 Intangible Assets (Expected Amortization Expense) HTML 52K
(Details)
18: R55 Other Accrued Liabilities (Details) HTML 50K
44: R56 Long-Term Debt (Narrative) (Details) HTML 155K
24: R57 Long-Term Debt (Schedule of Long-term Debt) HTML 44K
(Details)
91: R58 Long-Term Debt (Maturities of Long-term Debt) HTML 46K
(Details)
56: R59 Fair Value Measurements (Details) HTML 39K
75: R60 Stockholders' Equity (Details) HTML 47K
36: R61 Accumulated Other Comprehensive Income (Loss) HTML 39K
(Components of AOCI) (Details)
39: R62 Accumulated Other Comprehensive Income (Loss) HTML 44K
(Components of CI) (Details)
81: R63 Earnings Per Share (Details) HTML 69K
79: R64 Share-Based Compensation (Narrative) (Details) HTML 92K
58: R65 Share-Based Compensation (Restricted Shares HTML 59K
Activity) (Details)
80: R66 Share-Based Compensation (Stock Option Valuation HTML 39K
Assumptions) (Details)
35: R67 Share-Based Compensation (Stock Option Activity) HTML 72K
(Details)
62: R68 Income Taxes (Narrative) (Details) HTML 38K
92: R69 Commitments and Contingencies (Future Minimum HTML 57K
Rental Payments) (Details)
17: R70 Commitments and Contingencies (Long-term Supply HTML 41K
Agreement) (Details)
28: R71 Commitments and Contingencies (Short-term Supply HTML 29K
Agreement) (Details)
52: R72 Concentrations of Risk (Details) HTML 40K
23: R73 Business Segments (Information on Operating and HTML 74K
Reportable Segments) (Details)
95: R74 Business Segments (Revenue by Product) (Details) HTML 36K
32: R75 Business Segments (Assets by Segment) (Details) HTML 48K
25: R76 Gain on Settlement (Details) HTML 38K
27: R77 Condensed Consolidating Financial Statements HTML 140K
(Condensed Statement of Operations) (Details)
19: R78 Condensed Consolidating Financial Statements HTML 205K
(Condensed Balance Sheet) (Details)
22: R79 Condensed Consolidating Financial Statements HTML 194K
(Condensed Statement of Cash Flows) (Details)
68: R80 Condensed Consolidating Financial Statements HTML 163K
(Revisions) (Details)
26: R81 Subsequent Events (Details) HTML 43K
94: XML IDEA XML File -- Filing Summary XML 146K
40: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 3.79M
8: EX-101.INS XBRL Instance -- pbh-20120630 XML 4.94M
10: EX-101.CAL XBRL Calculations -- pbh-20120630_cal XML 259K
11: EX-101.DEF XBRL Definitions -- pbh-20120630_def XML 998K
12: EX-101.LAB XBRL Labels -- pbh-20120630_lab XML 1.88M
13: EX-101.PRE XBRL Presentations -- pbh-20120630_pre XML 1.24M
9: EX-101.SCH XBRL Schema -- pbh-20120630 XSD 204K
85: ZIP XBRL Zipped Folder -- 0001295947-12-000037-xbrl Zip 338K
| Exhibit 31.1 20120630 |
1. | I have reviewed this Quarterly Report on Form 10-Q of Prestige Brands Holdings, Inc.; |
2. | Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The
registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including
its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b. | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c. | Evaluated
the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d. | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the
registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
5. | The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the
registrant's board of directors (or persons performing the equivalent functions): |
a. | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
b. | Any
fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
Date: | |||
Chief Executive Officer | |||
(Principal Executive Officer) | |||
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 8/9/12 | None on these Dates | ||
| For Period end: | 6/30/12 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/15/24 Prestige Consumer Healthcare Inc. 10-K 3/31/24 136:13M 5/05/23 Prestige Consumer Healthcare Inc. 10-K 3/31/23 132:90M 5/06/22 Prestige Consumer Healthcare Inc. 10-K 3/31/22 130:15M 5/07/21 Prestige Consumer Healthcare Inc. 10-K 3/31/21 133:15M |